NCBI Home Page NCBI Site Search page NCBI Guide that lists and describes the NCBI resources
Conserved domains on  [gi|122063643|sp|Q7KNA0|]
View 

RecName: Full=Dymeclin

Protein Classification

dymeclin( domain architecture ID 10560863)

dymeclin is necessary for correct organization of Golgi apparatus

Graphical summary

 Zoom to residue level

show extra options »

Show site features     Horizontal zoom: ×

List of domain hits

Name Accession Description Interval E-value
Dymeclin pfam09742
Dyggve-Melchior-Clausen syndrome protein; Dymeclin (Dyggve-Melchior-Clausen syndrome protein) ...
1-676 0e+00

Dyggve-Melchior-Clausen syndrome protein; Dymeclin (Dyggve-Melchior-Clausen syndrome protein) contains a large number of leucine and isoleucine residues and a total of 17 repeated dileucine motifs. It is characteriztically about 700 residues long and present in plants and animals. Mutations in the gene coding for this protein in humans give rise to the disorder Dyggve-Melchior-Clausen syndrome (DMC, MIM 223800) which is an autosomal-recessive disorder characterized by the association of a spondylo-epi-metaphyseal dysplasia and mental retardation. DYM transcripts are widely expressed throughout human development and Dymeclin is not an integral membrane protein of the ER, but rather a peripheral membrane protein dynamically associated with the Golgi apparatus.


:

Pssm-ID: 462873  Cd Length: 645  Bit Score: 671.36  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 122063643    1 MGINVSRTADlgSNQWLQRFVGRQHIAHDDeAFWNGLLNYNIVLPENSQDQLNLDSRLEALCQSFIGNNLKTGNFGSLVT 80
Cdd:pfam09742   1 MGASSSKLSF--RNAYLQLLSGTQPISADD-PFWNQLLSFSLSIPLSSADVFLLEEALEPACEILALRNARTGNLATLLR 77
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 122063643   81 VFLEKTSELLSLSD---QESNMHVWQTFNALFIIRSLVKYINETGSEFQLLQHFEAMpnaellqaaleqqQQTPAESATI 157
Cdd:pfam09742  78 KFVERLVELKDSSRsasEQNDLFIWQALNALFLLRRILKYIIERASEEELLQHFEYE-------------NDDEGDEDEE 144
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 122063643  158 AMEATEqsaaaavpvivdgSKFETFIDALVNLIVVIPVKEFTYHLHLEAVNMLITLLSVHLFAQQPTDKSIVFRTVFKCQ 237
Cdd:pfam09742 145 GSNRDL-------------PLAESLLLALVDLLFTVPLTDSTYALHTELLNLLLVLLSEQLYSPPSPADTSIFNPFMDGK 211
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 122063643  238 ------HANVLMSALLHFVARIVEVPHTMFgSSSAGSFVF---------GIAESLLSIFTFrkqpdilkagqaaGGGELS 302
Cdd:pfam09742 212 csadssIALPLVTSLLNNFIAYDPVPSNSL-DSDGGSGVPynhllglvsDLASSLWLLPTL-------------GGSSES 277
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 122063643  303 QRFRTHYPLANQSLLLILILTNHCTAQ---------DNAYRTSLFSCADSKDspkqgavsFQIDFSAVYETLCTIVTIDQ 373
Cdd:pfam09742 278 ESEGTPEPLADQSLQLLLVLLDHGPTEdpvkspsggDNPYRNALSRLHDVED--------FQIVFSGLFRTLCNTVPSEQ 349
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 122063643  374 A-TLLLYLLLHRNERFYRFVMQQQDLEQLVIPILQTLYNAPDSNSHHIYMSLIVLLILSEDEGFNKNVHTIMLKNITWYT 452
Cdd:pfam09742 350 TlLLLLYKLLHSNSKFLNYVLSRSDVLDLLVPILELLYNARADNSHHIYMALIILLILSEDRNFNKRLHKPILKNVTWYS 429
                         490       500       510       520       530       540       550       560
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 122063643  453 ERTISEISLGGILILIVIRTIQYNMLKMRDKYLHTNCLAALANMSGHFRALHPYVAQRLVSLFETLARKHTRLDAQLKEP 532
Cdd:pfam09742 430 ERVPTEISLGSLLILVLIRTIQYNHTRLRDKYLHTNCLAILANMSPYFKNLSPYASQRLVSLFELLSKKHFKLLSLANGK 509
                         570       580       590       600       610       620       630       640
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 122063643  533 ADSavfvnvSTTPEDMLQDLSVLEEVLRMVLEILNSCLTNQLVYCPNLVYTLLYKRSVFEGFRSHHAFQDVIQNIDMVVG 612
Cdd:pfam09742 510 ASN------DLGSDDLAQDLSVNEEVLRLLLEILNSILQYQLDGNPNLVYALLRKREVFHQFANHPSFQDPLQNIDRVLQ 583
                         650       660       670       680       690       700
                  ....*....|....*....|....*....|....*....|....*....|....*....|....
gi 122063643  613 FFSSRLQRVQEQRGELGVNEVLEVISKGASQWSSDrlRKFPDLKFKYVEEDAPEEFFIPYVWTL 676
Cdd:pfam09742 584 FFSPRVEKACADSGLLSVSEILDIIQKGTLVGLLP--KPFPILKFKYVEEESPEEFFIPYVWSL 645
 
Name Accession Description Interval E-value
Dymeclin pfam09742
Dyggve-Melchior-Clausen syndrome protein; Dymeclin (Dyggve-Melchior-Clausen syndrome protein) ...
1-676 0e+00

Dyggve-Melchior-Clausen syndrome protein; Dymeclin (Dyggve-Melchior-Clausen syndrome protein) contains a large number of leucine and isoleucine residues and a total of 17 repeated dileucine motifs. It is characteriztically about 700 residues long and present in plants and animals. Mutations in the gene coding for this protein in humans give rise to the disorder Dyggve-Melchior-Clausen syndrome (DMC, MIM 223800) which is an autosomal-recessive disorder characterized by the association of a spondylo-epi-metaphyseal dysplasia and mental retardation. DYM transcripts are widely expressed throughout human development and Dymeclin is not an integral membrane protein of the ER, but rather a peripheral membrane protein dynamically associated with the Golgi apparatus.


Pssm-ID: 462873  Cd Length: 645  Bit Score: 671.36  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 122063643    1 MGINVSRTADlgSNQWLQRFVGRQHIAHDDeAFWNGLLNYNIVLPENSQDQLNLDSRLEALCQSFIGNNLKTGNFGSLVT 80
Cdd:pfam09742   1 MGASSSKLSF--RNAYLQLLSGTQPISADD-PFWNQLLSFSLSIPLSSADVFLLEEALEPACEILALRNARTGNLATLLR 77
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 122063643   81 VFLEKTSELLSLSD---QESNMHVWQTFNALFIIRSLVKYINETGSEFQLLQHFEAMpnaellqaaleqqQQTPAESATI 157
Cdd:pfam09742  78 KFVERLVELKDSSRsasEQNDLFIWQALNALFLLRRILKYIIERASEEELLQHFEYE-------------NDDEGDEDEE 144
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 122063643  158 AMEATEqsaaaavpvivdgSKFETFIDALVNLIVVIPVKEFTYHLHLEAVNMLITLLSVHLFAQQPTDKSIVFRTVFKCQ 237
Cdd:pfam09742 145 GSNRDL-------------PLAESLLLALVDLLFTVPLTDSTYALHTELLNLLLVLLSEQLYSPPSPADTSIFNPFMDGK 211
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 122063643  238 ------HANVLMSALLHFVARIVEVPHTMFgSSSAGSFVF---------GIAESLLSIFTFrkqpdilkagqaaGGGELS 302
Cdd:pfam09742 212 csadssIALPLVTSLLNNFIAYDPVPSNSL-DSDGGSGVPynhllglvsDLASSLWLLPTL-------------GGSSES 277
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 122063643  303 QRFRTHYPLANQSLLLILILTNHCTAQ---------DNAYRTSLFSCADSKDspkqgavsFQIDFSAVYETLCTIVTIDQ 373
Cdd:pfam09742 278 ESEGTPEPLADQSLQLLLVLLDHGPTEdpvkspsggDNPYRNALSRLHDVED--------FQIVFSGLFRTLCNTVPSEQ 349
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 122063643  374 A-TLLLYLLLHRNERFYRFVMQQQDLEQLVIPILQTLYNAPDSNSHHIYMSLIVLLILSEDEGFNKNVHTIMLKNITWYT 452
Cdd:pfam09742 350 TlLLLLYKLLHSNSKFLNYVLSRSDVLDLLVPILELLYNARADNSHHIYMALIILLILSEDRNFNKRLHKPILKNVTWYS 429
                         490       500       510       520       530       540       550       560
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 122063643  453 ERTISEISLGGILILIVIRTIQYNMLKMRDKYLHTNCLAALANMSGHFRALHPYVAQRLVSLFETLARKHTRLDAQLKEP 532
Cdd:pfam09742 430 ERVPTEISLGSLLILVLIRTIQYNHTRLRDKYLHTNCLAILANMSPYFKNLSPYASQRLVSLFELLSKKHFKLLSLANGK 509
                         570       580       590       600       610       620       630       640
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 122063643  533 ADSavfvnvSTTPEDMLQDLSVLEEVLRMVLEILNSCLTNQLVYCPNLVYTLLYKRSVFEGFRSHHAFQDVIQNIDMVVG 612
Cdd:pfam09742 510 ASN------DLGSDDLAQDLSVNEEVLRLLLEILNSILQYQLDGNPNLVYALLRKREVFHQFANHPSFQDPLQNIDRVLQ 583
                         650       660       670       680       690       700
                  ....*....|....*....|....*....|....*....|....*....|....*....|....
gi 122063643  613 FFSSRLQRVQEQRGELGVNEVLEVISKGASQWSSDrlRKFPDLKFKYVEEDAPEEFFIPYVWTL 676
Cdd:pfam09742 584 FFSPRVEKACADSGLLSVSEILDIIQKGTLVGLLP--KPFPILKFKYVEEESPEEFFIPYVWSL 645
 
Name Accession Description Interval E-value
Dymeclin pfam09742
Dyggve-Melchior-Clausen syndrome protein; Dymeclin (Dyggve-Melchior-Clausen syndrome protein) ...
1-676 0e+00

Dyggve-Melchior-Clausen syndrome protein; Dymeclin (Dyggve-Melchior-Clausen syndrome protein) contains a large number of leucine and isoleucine residues and a total of 17 repeated dileucine motifs. It is characteriztically about 700 residues long and present in plants and animals. Mutations in the gene coding for this protein in humans give rise to the disorder Dyggve-Melchior-Clausen syndrome (DMC, MIM 223800) which is an autosomal-recessive disorder characterized by the association of a spondylo-epi-metaphyseal dysplasia and mental retardation. DYM transcripts are widely expressed throughout human development and Dymeclin is not an integral membrane protein of the ER, but rather a peripheral membrane protein dynamically associated with the Golgi apparatus.


Pssm-ID: 462873  Cd Length: 645  Bit Score: 671.36  E-value: 0e+00
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 122063643    1 MGINVSRTADlgSNQWLQRFVGRQHIAHDDeAFWNGLLNYNIVLPENSQDQLNLDSRLEALCQSFIGNNLKTGNFGSLVT 80
Cdd:pfam09742   1 MGASSSKLSF--RNAYLQLLSGTQPISADD-PFWNQLLSFSLSIPLSSADVFLLEEALEPACEILALRNARTGNLATLLR 77
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 122063643   81 VFLEKTSELLSLSD---QESNMHVWQTFNALFIIRSLVKYINETGSEFQLLQHFEAMpnaellqaaleqqQQTPAESATI 157
Cdd:pfam09742  78 KFVERLVELKDSSRsasEQNDLFIWQALNALFLLRRILKYIIERASEEELLQHFEYE-------------NDDEGDEDEE 144
                         170       180       190       200       210       220       230       240
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 122063643  158 AMEATEqsaaaavpvivdgSKFETFIDALVNLIVVIPVKEFTYHLHLEAVNMLITLLSVHLFAQQPTDKSIVFRTVFKCQ 237
Cdd:pfam09742 145 GSNRDL-------------PLAESLLLALVDLLFTVPLTDSTYALHTELLNLLLVLLSEQLYSPPSPADTSIFNPFMDGK 211
                         250       260       270       280       290       300       310       320
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 122063643  238 ------HANVLMSALLHFVARIVEVPHTMFgSSSAGSFVF---------GIAESLLSIFTFrkqpdilkagqaaGGGELS 302
Cdd:pfam09742 212 csadssIALPLVTSLLNNFIAYDPVPSNSL-DSDGGSGVPynhllglvsDLASSLWLLPTL-------------GGSSES 277
                         330       340       350       360       370       380       390       400
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 122063643  303 QRFRTHYPLANQSLLLILILTNHCTAQ---------DNAYRTSLFSCADSKDspkqgavsFQIDFSAVYETLCTIVTIDQ 373
Cdd:pfam09742 278 ESEGTPEPLADQSLQLLLVLLDHGPTEdpvkspsggDNPYRNALSRLHDVED--------FQIVFSGLFRTLCNTVPSEQ 349
                         410       420       430       440       450       460       470       480
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 122063643  374 A-TLLLYLLLHRNERFYRFVMQQQDLEQLVIPILQTLYNAPDSNSHHIYMSLIVLLILSEDEGFNKNVHTIMLKNITWYT 452
Cdd:pfam09742 350 TlLLLLYKLLHSNSKFLNYVLSRSDVLDLLVPILELLYNARADNSHHIYMALIILLILSEDRNFNKRLHKPILKNVTWYS 429
                         490       500       510       520       530       540       550       560
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 122063643  453 ERTISEISLGGILILIVIRTIQYNMLKMRDKYLHTNCLAALANMSGHFRALHPYVAQRLVSLFETLARKHTRLDAQLKEP 532
Cdd:pfam09742 430 ERVPTEISLGSLLILVLIRTIQYNHTRLRDKYLHTNCLAILANMSPYFKNLSPYASQRLVSLFELLSKKHFKLLSLANGK 509
                         570       580       590       600       610       620       630       640
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 122063643  533 ADSavfvnvSTTPEDMLQDLSVLEEVLRMVLEILNSCLTNQLVYCPNLVYTLLYKRSVFEGFRSHHAFQDVIQNIDMVVG 612
Cdd:pfam09742 510 ASN------DLGSDDLAQDLSVNEEVLRLLLEILNSILQYQLDGNPNLVYALLRKREVFHQFANHPSFQDPLQNIDRVLQ 583
                         650       660       670       680       690       700
                  ....*....|....*....|....*....|....*....|....*....|....*....|....
gi 122063643  613 FFSSRLQRVQEQRGELGVNEVLEVISKGASQWSSDrlRKFPDLKFKYVEEDAPEEFFIPYVWTL 676
Cdd:pfam09742 584 FFSPRVEKACADSGLLSVSEILDIIQKGTLVGLLP--KPFPILKFKYVEEESPEEFFIPYVWSL 645
Hid1 pfam12722
High-temperature-induced dauer-formation protein; Hid1 (high-temperature-induced ...
383-596 1.48e-07

High-temperature-induced dauer-formation protein; Hid1 (high-temperature-induced dauer-formation protein 1) represents proteins of approximately 800 residues long and is conserved from fungi to humans. Functionally it might be involved in vesicle secretion or be an inter-cellular signalling protein or be a novel insulin receptor. It was previously thought to contain up to seven potential transmembrane domains separated by regions of low complexity. However, biochemical membrane fraction analysis demonstrate that HID-1 is a peripheral membrane protein tightly associated with the Golgi apparatus but not a transmembrane protein predicted by the bioinformatic programs. Furthermore, it contains a conserved N-terminal myristoylation site was required for HID-1 binding to the Golgi apparatus.


Pssm-ID: 463680 [Multi-domain]  Cd Length: 804  Bit Score: 54.72  E-value: 1.48e-07
                          10        20        30        40        50        60        70        80
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 122063643  383 HRNERFYRFVMQQQDLEQLVIPILQTLYNAPDSNSH--HIYMSLIVLLILSEDEGFNKNVHTIMLKNITWYTERTIS-EI 459
Cdd:pfam12722 380 QCNKRFRSYVIDTSRALDLLVPILYYAFEYRSDPSKkgLVKICVFILLLLSGEKNFGVRLNKPFEAQETLPTSIRIPfFT 459
                          90       100       110       120       130       140       150       160
                  ....*....|....*....|....*....|....*....|....*....|....*....|....*....|....*....|
gi 122063643  460 SLGGILILIVIRTIqYNMLKMRDKYLHTNCLAALANMSGHFRALHPYVAQRLVSLFETLarkhtrldaqlkepadsavfv 539
Cdd:pfam12722 460 GTYADFLITVIHKL-ITTGKGRLSELVPCLLEILVNLSPYLKGLSMVACSKLLQLFESF--------------------- 517
                         170       180       190       200       210
                  ....*....|....*....|....*....|....*....|....*....|....*..
gi 122063643  540 nvSTTPedMLQDLSVLEEVLRMVLEILNSCLTNQLVYCPNLVYTLLYKRSVFEGFRS 596
Cdd:pfam12722 518 --SSPS--FLLANPSNHKLLASLLEAFNNAIQYQFDGNPNLVYSILRNRKVFEALRN 570
 
Blast search parameters
Data Source: Precalculated data, version = cdd.v.3.21
Preset Options:Database: CDSEARCH/cdd   Low complexity filter: no  Composition Based Adjustment: yes   E-value threshold: 0.01

References:

  • Wang J et al. (2023), "The conserved domain database in 2023", Nucleic Acids Res.51(D)384-8.
  • Lu S et al. (2020), "The conserved domain database in 2020", Nucleic Acids Res.48(D)265-8.
  • Marchler-Bauer A et al. (2017), "CDD/SPARCLE: functional classification of proteins via subfamily domain architectures.", Nucleic Acids Res.45(D)200-3.
Help | Disclaimer | Write to the Help Desk
NCBI | NLM | NIH